We are live on ! Find out more
BP

Ballentine Partners Portfolio holdings

AUM $8.18B
1-Year Est. Return 27.59%
This Fund
S&P 500
This Quarter Est. Return
+1.21%
1 Year Est. Return
+27.59%
3 Year Est. Return
+76.88%
5 Year Est. Return
+72.28%
10 Year Est. Return
+235.36%
AUM
$1.19B
AUM Growth
+$49.5M
Cap. Flow
+$37.2M
Cap. Flow %
3.14%
Top 10 Hldgs %
70.04%
Holding
247
New
15
Increased
82
Reduced
97
Closed
10

Sector Composition

Rank Sector Weight
1 Industrials 1.95%
2 Consumer Discretionary 1.88%
3 Healthcare 1.47%
4 Technology 1.41%
5 Financials 1.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDA icon
176
NVIDIA
NVDA
$5.01T
$238K 0.02%
+201,960
New +$208K
CLB icon
177
Core Laboratories
CLB
$538M
$237K 0.02%
1,905
-100
-5% -$12.1K
BDX icon
178
Becton Dickinson
BDX
$43.1B
$235K 0.02%
+1,420
New +$227K
NGG icon
179
National Grid
NGG
$82.7B
$233K 0.02%
+3,252
New +$225K
RAI
180
DELISTED
Reynolds American Inc
RAI
$232K 0.02%
4,307
+59
+1% +$2.96K
AMT icon
181
American Tower
AMT
$77.7B
$231K 0.02%
2,023
-82
-4% -$8.73K
ROST icon
182
Ross Stores
ROST
$76.6B
$229K 0.02%
4,048
+19
+0.5% +$1.05K
STT icon
183
State Street
STT
$50.9B
$229K 0.02%
4,242
+231
+6% +$13.8K
APTV icon
184
Aptiv
APTV
$12B
$228K 0.02%
3,630
-31
-0.8% -$2.17K
CP icon
185
Canadian Pacific Kansas City
CP
$82B
$228K 0.02%
8,810
-480
-5% -$13K
KMB icon
186
Kimberly-Clark
KMB
$36.4B
$228K 0.02%
+1,659
New +$217K
BKNG icon
187
Booking.com
BKNG
$138B
$226K 0.02%
4,525
-3,225
-42% -$167K
EW icon
188
Edwards Lifesciences
EW
$47.6B
$222K 0.02%
+6,645
New +$227K
REGN icon
189
Regeneron Pharmaceuticals
REGN
$68.8B
$222K 0.02%
638
+13
+2% +$5.01K
XLK icon
190
State Street Technology Select Sector SPDR ETF
XLK
$115B
$220K 0.02%
10,152
LNKD
191
DELISTED
LinkedIn Corporation
LNKD
$219K 0.02%
+1,158
New +$160K
BLK icon
192
Blackrock
BLK
$164B
$218K 0.02%
635
-333
-34% -$117K
LOB icon
193
Live Oak Bancshares
LOB
$1.95B
$218K 0.02%
15,430
-4,900
-24% -$74.7K
WTW icon
194
Willis Towers Watson
WTW
$27.9B
$218K 0.02%
1,748
+11
+0.6% +$1.36K
IMS
195
DELISTED
IMS HEALTH HLDGS INC COM STK (DE)
IMS
$216K 0.02%
8,521
HOLX
196
DELISTED
Hologic
HOLX
$215K 0.02%
6,210
+51
+0.8% +$1.77K
NLSN
197
DELISTED
Nielsen Holdings plc
NLSN
$214K 0.02%
4,103
-56
-1% -$2.95K
CCL icon
198
Carnival Corporation Ltd
CCL
$36.1B
$213K 0.02%
4,804
-104
-2% -$5.1K
DE icon
199
Deere & Co
DE
$170B
$213K 0.02%
2,639
-160
-6% -$13.1K
CSX icon
200
CSX Corp
CSX
$98.6B
$211K 0.02%
24,336
-42
-0.2% -$366

Similar funds

Ballentine Partners's Q2 2016 Portfolio in Review

As of Q2 2016, Ballentine Partners held 247 positions worth $1.19B, up 4.4% from $1.14B the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Ballentine Partners deployed $37.2M of net new capital in Q2 2016, opening 15 new positions and adding to 82 existing holdings. Its largest new stake was LKQ Corp: 354,618 shares worth $11.2M.

By sector, the portfolio is most concentrated in Industrials at 2% of assets, down from 2.1% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Vanguard FTSE Emerging Markets ETF, an estimated $4.63M trimmed.

  • Ballentine Partners's largest Q2 2016 buy was LKQ Corp: 354,618 shares worth $11.2M.
  • Ballentine Partners added most to Vanguard Total Stock Market ETF in Q2 2016, an estimated $19.8M increase.
  • Ballentine Partners's biggest Q2 2016 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $4.63M.
  • Ballentine Partners fully exited Endurance International Group Holdings, Inc. in Q2 2016, selling an estimated $4.66M.
  • Ballentine Partners's ten largest holdings make up 70% of its $1.19B portfolio in Q2 2016.
  • Ballentine Partners opened 15 new positions and closed 10 in Q2 2016.
  • Ballentine Partners's portfolio value rose 4.4% quarter-over-quarter to $1.19B.

Based on Ballentine Partners's 13F filing for Q2 2016, filed 3 Aug 2016.